The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Judge Strikes Down Trump's $100K H-1B Visa Fee

A federal judge has struck down President Trump's $100,000 fee on H-1B visas, ruling that the charge amounted to an unlawful tax on the program for highly skilled foreign workers, Healthcare Dive reports. The decision is a win for healthcare employers, who warned the fee would choke off a critical pipeline of clinical talent.

The stakes are high for hospitals and health systems. Foreign-trained physicians fill a large share of residency slots and staff positions, particularly in rural and underserved areas where domestic recruiting falls short. A six-figure surcharge per visa would have made hiring these workers prohibitively expensive for many providers already operating on thin margins.

Medical groups cheered the ruling. For now, employers can continue sponsoring H-1B workers without the added cost, though the administration could appeal. Health systems planning their recruiting and budgeting should watch for further legal action, since the rule's future remains uncertain even as the immediate threat recedes.

More in Government

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.

Government

Feds Launch False Claims Act Self-Disclosure Pilot

HHS and the DOJ Civil Division have launched a six-month pilot letting healthcare companies self-report potential civil False Claims Act violations and settle through a coordinated civil release.

Why it matters: The pilot reshapes how hospitals and healthcare firms weigh self-reporting against federal fraud enforcement, with real consequences for compliance strategy.

Government

GOP Pushes Fraud Message to Deflect Healthcare Cost Anger

Republicans are elevating healthcare fraud as a midterm message to deflect voter anger over costs, while Democrats say the push targets blue states to justify Medicaid and ACA cuts.

Why it matters: Fraud-focused enforcement could reshape Medicaid and ACA funding, audits, and eligibility for the tens of millions who depend on those programs.